Human trial
ARA-290 primary study · PMID 23168581
22 adults with sarcoidosis-associated small-fiber neuropathy in a blinded pilot trial.
Reported findings. Neuropathy symptom scores improved relative to placebo in this small study.
Nonresponse. BPI pain and fatigue improved equivalently in both arms; SFNSL superiority does not generalize to every measure.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Small, short exploratory trial. It does not establish general injury recovery or commercial-vial equivalence.
Preparation: Source preparation; commercial equivalence unverified. Route: intravenous
Read original source ↗Editorial review 2026-10-09. Clinician review pending.